SCHEMBL31065387

SCHEMBL31065387

OC(c1ccc(Cl)c(Cl)c1)C(F)F

nearest known ligand 0.44

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 14/20 0.42
SLC6A4 P31645 14/20 0.42
SLC6A3 Q01959 14/20 0.42
CYP3A4 P08684 13/20 0.42
CYP2D6 P10635 13/20 0.42
KCNH2 Q12809 9/20 0.42
AHR P35869 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31065375 0.83 SLC6A2 (0.37) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL31065377 0.82 CYP3A4 (0.41) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL20604406 0.78 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL20604356 0.78 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL20604354 0.78 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL19136417 0.77 HSD17B10 (0.40) CYP3A4AHR
SCHEMBL2654115 0.77 AHR (0.50) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL10680633 0.77 TRPV4 (0.55) SLC6A2SLC6A4SLC6A3CYP3A4AHR
SCHEMBL14341707 0.75 KDM4E (0.58) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL31065350 0.75 TSHR (0.42) SLC6A2SLC6A4SLC6A3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025262243-A1 THIENO- AND THIAZOLOPYRIMIDINE-2,6-DIONES AND USE THEREOF AS IMMUNOMODULATORS INVIOS GMBH (AT) 2025-12-26 WO disclosed
EP-4602044-A1 SUBSTITUTED 3,7-DIHYDRO-1 H-PURINE-2,6-DIONES AND USE THEREOF invIOs GmbH (AT) 2025-08-20 EP disclosed
WO-2024133605-A1 SUBSTITUTED 3,7-DIHYDRO-1 H-PURINE-2,6-DIONES AND USE THEREOF INVIOS GMBH (AT) 2024-06-27 WO disclosed